2-chloromethyl-3-methoxynaphthalene | 153958-79-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2-chloromethyl-3-methoxynaphthalene
• 英文别名: 2-methoxy-3-(chloromethyl)naphthalene；2-(Chloromethyl)-3-methoxynaphthalene
• CAS: 153958-79-3
• 化学式: C₁₂H₁₁ClO
• 分子量: 206.672
• InChiKey: CQSZAJQHIUQXOT-UHFFFAOYSA-N

物化性质

• 沸点：
  328.2±17.0 °C(Predicted)
• 密度：
  1.179±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-chloromethyl-3-methoxynaphthalene 在 盐酸羟胺 、 sodium methylate 作用下， 以 甲醇 、 水 、 二甲基亚砜 、 乙腈 为溶剂， 反应 20.5h， 生成 N-Hydroxy-2-(3-methoxy-naphthalen-2-yl)-acetamidine
  参考文献：
  名称：

  Antihyperglycemic activity of novel naphthalenylmethyl-3H-1,2,3,5-oxathiadiazole 2-oxides

  摘要：

  A series of naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides was prepared and tested for antihyperglycemic activity in the db/db mouse, a model for type 2 (non-insulin dependent) diabetes mellitus. Substitution at the 1-, 5-, or 8-positions of the naphthalene ring with a halogen was found to be beneficial to antihyperglycemic activity. 4-[(5-Chloronaphthalen-2-yl)methyl]-3H-1,2,3,5-oxathiadiazole 2-oxide (45), one of the most potent compounds in this series, was selected for further pharmacological evaluation.

  DOI：

  10.1021/jm00069a006
• 作为产物：
  描述：

  3-甲氧基-2-萘甲醇 在 氯化亚砜 、 zinc(II) chloride 作用下， 以 1,4-二氧六环 为溶剂， 反应 0.67h， 生成 2-chloromethyl-3-methoxynaphthalene
  参考文献：
  名称：

  Antihyperglycemic activity of novel naphthalenylmethyl-3H-1,2,3,5-oxathiadiazole 2-oxides

  摘要：

  A series of naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides was prepared and tested for antihyperglycemic activity in the db/db mouse, a model for type 2 (non-insulin dependent) diabetes mellitus. Substitution at the 1-, 5-, or 8-positions of the naphthalene ring with a halogen was found to be beneficial to antihyperglycemic activity. 4-[(5-Chloronaphthalen-2-yl)methyl]-3H-1,2,3,5-oxathiadiazole 2-oxide (45), one of the most potent compounds in this series, was selected for further pharmacological evaluation.

  DOI：

  10.1021/jm00069a006

文献信息

• Synthesis and fluoride-induced chemiluminescent decomposition of bicyclic dioxetanes substituted with a 2-hydroxynaphthyl group
  作者：Naoyuki Hoshiya、Natsuki Fukuda、Hidetoshi Maeda、Nobuko Watanabe、Masakatsu Matsumoto

  DOI：10.1016/j.tet.2006.03.082

  日期：2006.6

  efficiency, and that dioxetane 1aA exhibited chemiluminescence with the highest efficiency among those for the oxynaphthyl-substituted dioxetanes hitherto known. The significant change in chemiluminescent efficiency depending on the substitution pattern was clarified to be attributed to the marked change in singlet-chemiexcitation efficiency for charge-transfer-induced chemiluminescence (CTICL) of 1aA–1eA

  合成了5个带有2-羟基萘基的双环二氧杂环丁烷1aA - 1eA，并使用四丁基氟化铵（TBAF）作为DMSO中的碱检查了它们的化学发光分解。发现这些二氧杂环丁烷完全保持了作为萘环上的引发剂的羟基的取代模式与其化学发光效率之间的'奇/偶'关系，并且二氧环乙烷1aA在迄今为止已知的氧萘基取代的二氧杂环丁烷中，化学发光显示出最高的化学发光效率。化学发光效率的显着变化取决于取代模式，已明确归因于1aA – 1eA电荷转移诱导的化学发光（CTICL）的单重态化学激发效率的显着变化。关于CTICL分解的速率，观察到1aA – 1dA的“奇/偶”关系。
• Amides tricycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
  申请人：ADIR ET COMPAGNIE

  公开号：EP0737670A1

  公开（公告）日：1996-10-16

  L'invention concerne les composés de formule (I) : dans laquelle R7, R8, Y, n et A sont tels que définis dans la description. Médicaments.

  本发明涉及式 (I) 化合物： 其中 R7、R8、Y、n 和 A 如说明书中所定义。 药物。
• COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS, METHOD OF SEPARATION, AND USE THEREOF
  申请人：Ustav organicke chemie a biochemie AV CR, v.v.i.

  公开号：EP3492460A1

  公开（公告）日：2019-06-05

  The present invention relates to the use of the compounds of general formula (I): wherein X, Y, Z, L, R and R1 are as described herein; for chromatographic separation of rare earth elements, as well as to the method of the separation of rare earth elements.

  本发明涉及通式（I）化合物的用途： 其中 X、Y、Z、L、R 和 R1 如本文所述； 以及分离稀土元素的方法。
• Synthesis of 2-Amido-2,3-dihydro-1<i>H</i>-phenalene Derivatives as New Conformationally Restricted Ligands for Melatonin Receptors
  作者：Monique Mathé-Allainmat、Florence Gaudy、Sames Sicsic、Anne-Laure Dangy-Caye、Shuren Shen、Béatrice Brémont、Zohra Benatalah、Michel Langlois、Pierre Renard、Philippe Delagrange

  DOI：10.1021/jm960219h

  日期：1996.1.1

  Tetrahydroanthracene, tetrahydrophenanthrene, and tetrahydrophenalene moieties were used to design novel constrained melatoninergic agents. Compounds 1 and 2 were synthesized from the cyclization of the aryl succinic acids 6a,b followed by catalytic reduction, Curtius degradation to the amino derivatives, and acetylation. The phenalene derivatives 3 were prepared by cyclization of the aza lactones of the corresponding alpha-N-acetyl amino acids. The ketone derivatives were reduced directly by catalytic hydrogenation to produce the compounds 3. The different compounds were evaluated in vitro in binding assays using 2-[I-125]iodomelatonin and chicken brain membranes. Melatonin and 2-acetamido-8-methoxytetralin were used as the reference compounds. The results showed the superiority of the dihydrophenalene framework 3 over tho se of tetrahydro anthracene and tetrahydrophenanthrene. 3a had relatively good affinity for melatonin receptors (K-i = 28.7 nM). Introduction of an additional methoxy group gave a derivative (3c) with nanomolar affinity (K-i = 0.7 nM), confirming the existence of a secondary binding site in the receptor which has been described previously. An increase in the affinity was also observed with the propionamido derivative 3e (K-i = 6.0 nM). The potential agonist properties of the compound 3e were evaluated on the dermal melanocytes of Xenopus laevis tadpoles. At the concentration of 2.3 nM (5 x K-i), melatonin gave melanophore index value of 1. Similarly to melatonin, 3e was shown to be a potent agonist of the melanosome aggregation.
• Design and Synthesis of 2-Naphthoate Esters as Selective Dopamine D₄ Antagonists
  作者：Izzy Boyfield、Thomas H. Brown、Martyn C. Coldwell、David G. Cooper、Michael S. Hadley、Jim J. Hagan、Maureen A. Healy、Amanda Johns、Ron J. King、Derek N. Middlemiss、David J. Nash、Graham J. Riley、Emma E. Scott、Stephen A. Smith、Geoffrey Stemp

  DOI：10.1021/jm960017l

  日期：1996.1.1